HIGH SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR AND ABSENCE OF DETECTABLE LEVELS OF SOLUBLE CD30 MOLECULE - A SPECIFIC DIAGNOSTIC COMBINATION FOR HAIRY-CELL LEUKEMIA

被引：2

作者：

PIZZOLO, G

DALLENBACH, F

VINANTE, F

MOROSATO, L

DESABATA, D

AMBROSETTI, A

NADALI, G

CHILOSI, M

SEMENZATO, G

FALINI, B

JOSIMOVICALASEVIC, O

DIAMANTSTEIN, T

STEIN, H

机构：

[1] Department of Hematology, Institute of Pathology, Verona University School of Medicine

[2] Medical Clinic, Department of Clinical Medicine, Padova University School of Medicine

[3] Department of Hematology, Perugia University School of Medicine

[4] Immunology, Klinikum Steglitz, Free University of Berlin

来源：

LEUKEMIA & LYMPHOMA | 1992年 / 6卷 / 4-5期

关键词：

HAIRY CELL LEUKEMIA; SOLUBLE CD30; SOLUBLE INTERLEUKIN-2 RECEPTOR;

D O I：

10.3109/10428199209053571

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Hairy cell leukemia (HCL) is almost constantly characterized by the presence of very high levels of a soluble form of the interleukin-2 receptor (sIL-2R). Since several other hematologic neoplasias also display very high levels of sIL-2R, this feature cannot be considered specific for HCL. On the other hand, most of the above hematologic disorders are also characterized by the presence of detectable levels of the soluble CD30 molecule (sCD30). In the present study we investigated the sera from 22 patients with HCL for the presence of detectable circulating levels of sCD30 in combination with the detection of sIL-2R. In this report we demonstrate that the high serum levels of sIL-2R found in all HCL patients were never associated with the presence of sCD30. Since this pattern is unlikely to be found in neoplastic conditions other than HCL, we suggest that the combined serum determinations of sIL-2R and sCD30 be used as a reliable additional tool for the diagnosis of HCL. © 1992 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.

引用

页码：385 / 388

页数：4

共 19 条

[1]

Korsmeyer S.J., Greene W.C., Cossman J., Hsu S.M., Jensen J.P., Neckers L.M., Marshall G.L., Bakhshi A., Depper J.M., Leonard W.J., Jaffe E.S., Waldmann T.A., Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia, Proceedings of the National Academy of Sciences of the United States of America, 80, pp. 4522-4526, (1983)

[2]

Pizzolo G., Chilosi M., Semenzato G., Caligaris-Cappio F., Fiore-Donati L., Perona G., Janossy G., Immunohistological analysis of Tac antigen expression in tissues involved by Hodgkin's disease, British Journal of Cancer, 50, pp. 415-417, (1984)

[3]

Waldmann T.A., Greene W.C., Sarin P.S., Saxinger C., Blayney D.W., Blattner W.A., Goldman C.K., Bongiovanni K., Sharrow S., Depper G.M., Leonard W., Uchiyama T., Gallo R.C., Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sezary leukemia and their distinction using anti-Tac monoclonal antibody identifying the human receptor to T cell growth factor, Journal of Clinical Investigation, 73

[4]

Greene W.C., Leonard W.J., Depper J.M., Nelson D.L., Waldmann T.A., The human interleukin-2 receptor: normal and abnormal expression in T cell and in leukemias induced by the human T-lymphotropic retroviruses, Annals of Internal Medicine, 105, pp. 560-572, (1986)

[5]

Stein H., Gerdes J., Falini B., Phenotypic and genotypic markers of malignant lymphomas: cellular origin of Hodgkin's and Sternberg-Reed cells and implications for the classification of T-cell and B-cell lymphomas, Pathology of Cell Receptors and Tumor Markers, (1987)

[6]

Rubin L.A., Kurman C.C., Fritz M.E., Biddison W.E., Boutin B., Yarchoan R., Nelson D.L., Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro, Journal of Immunology, 135, pp. 3172-3177, (1985)

[7]

Chilosi M., Semenzato G., Cetto G.L., Ambrosetti A., Fiore-Donati L., Perona G., Berton G., Lestani M., Scarpa A., Agostini C., Trentin L., Zambello R., Masciarelli M., Dazzi F., Vinante F., Caligaris-Cappio F., Pizzolo G., Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha interferon therapy on clinical parameters and natural killer in vitro activity, Blood, 70, pp. 1530-1535, (1987)

[8]

Pizzolo G., Chilosi M., Semenzato G., The soluble interleukin-2 receptor in haematological disorders, British Journal of Haematology, 67, pp. 377-380, (1987)

[9]

Semenzato G., Foa R., Agostini C., Zambello R., Trentin L., Vinante F., Benedetti F., Chilosi M., Pizzolo G., High serum levels of soluble interleukin 2 receptor in patients with chronic lymphocytic leukemia, Blood, 70, pp. 396-400, (1987)

[10]

Ambrosetti A., Semenzato G., Prior M., Chilosi M., Vinante F., Vincenzi C., Zanotti R., Trentin L., Portuese A., Menestrina F., Perona G., Agostini C., Todeschini G., Pizzolo G., Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk, British Journal of Haematology, 73, pp. 181-186, (1989)

← 1 2 →